Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Psychemedics Corporation

    NASDAQ: PMD · Real-Time Price · USD
    2.67
    0.00 (0.00%)
    At close: Jun 17, 2025, 10:00 PM

    Psychemedics Statistics

    Share Statistics

    Psychemedics has 5.89M shares outstanding. The number of shares has increased by 1.21% in one year.

    Shares Outstanding

    n/a
    		 5.89M

    Shares Change (YoY)

    n/a
    		 1.21%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0.34%

    Shares Floating

    n/a
    		 4.31M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,569

    FTD / Avg. Volume

    n/a
    		 17.94%

    Short Selling Information

    The latest short interest is 38.6K, so 0.65% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 38.6K

    Short % of Shares Out

    n/a
    		 0.65%

    Short % of Float

    n/a
    		 0.87%

    Short Ratio (days to cover)

    n/a
    		 1.92

    Valuation Ratios

    The PE ratio is -7.06 and the forward PE ratio is null. Psychemedics's PEG ratio is 0.13.

    PE Ratio

    n/a
    		 -7.06

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0.67

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 2.56

    P/FCF Ratio

    n/a
    		 15.61

    PEG Ratio

    n/a
    		 0.13
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Psychemedics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.23.

    Current Ratio

    n/a
    		 1.82

    Quick Ratio

    n/a
    		 1.82

    Debt / Equity

    n/a
    		 0.23

    Debt / EBITDA

    n/a
    		 6.1

    Debt / FCF

    n/a
    		 1.38

    Interest Coverage

    n/a
    		 -72.81

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $169,698.28

    Profits Per Employee

    n/a
    		 $-16,043.1

    Employee Count

    n/a
    		 116

    Asset Turnover

    n/a
    		 2.37

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -55K

    Effective Tax Rate

    n/a
    		 2.87%

    Stock Price Statistics

    The stock price has increased by 14.59% in the last 52 weeks. The beta is 0.67, so Psychemedics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.67

    52-Week Price Change

    n/a
    		 14.59%

    50-Day Moving Average

    n/a
    		 2.08

    200-Day Moving Average

    n/a
    		 2.27

    Relative Strength Index (RSI)

    n/a
    		 54.03

    Average Volume (20 Days)

    n/a
    		 31,047

    Income Statement

    In the last 12 months, Psychemedics had revenue of 19.68M and earned -1.86M in profits. Earnings per share was -0.32.

    Revenue

    n/a
    		 19.68M

    Gross Profit

    n/a
    		 7.1M

    Operating Income

    n/a
    		 -1.89M

    Net Income

    n/a
    		 -1.86M

    EBITDA

    n/a
    		 191K

    EBIT

    n/a
    		 -1.89M

    Earnings Per Share (EPS)

    n/a
    		 -0.32
    Full Income Statement

    Balance Sheet

    The company has 1.42M in cash and 1.17M in debt, giving a net cash position of 251K.

    Cash & Cash Equivalents

    n/a
    		 1.42M

    Total Debt

    n/a
    		 1.17M

    Net Cash

    n/a
    		 251K

    Retained Earnings

    n/a
    		 -18.63M

    Total Assets

    n/a
    		 8.32M

    Working Capital

    n/a
    		 2.23M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 929K and capital expenditures -87K, giving a free cash flow of 842K.

    Operating Cash Flow

    n/a
    		 929K

    Capital Expenditures

    n/a
    		 -87K

    Free Cash Flow

    n/a
    		 842K

    FCF Per Share

    n/a
    		 0.14
    Full Cash Flow Statement

    Margins

    Gross margin is 36.07%, with operating and profit margins of -9.62% and -9.45%.

    Gross Margin

    n/a
    		 36.07%

    Operating Margin

    n/a
    		 -9.62%

    Pretax Margin

    n/a
    		 -9.73%

    Profit Margin

    n/a
    		 -9.45%

    EBITDA Margin

    n/a
    		 0.97%

    EBIT Margin

    n/a
    		 -9.62%

    FCF Margin

    n/a
    		 4.28%

    Dividends & Yields

    PMD pays an annual dividend of $0.35, which amounts to a dividend yield of 5.68%.

    Dividend Per Share

    n/a
    		 $0.35

    Dividend Yield

    n/a
    		 5.68%

    Dividend Growth (YoY)

    n/a
    		 0%

    Payout Ratio

    n/a
    		 -68.63%

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for PMD.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 1, 2002. It was a backward split with a ratio of 1:4.

    Last Split Date

    n/a
    		 Aug 1, 2002

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:4

    Scores

    Altman Z-Score

    n/a
    		 1.76

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist